NAD Reminds Industry That The Door Is Open For Competitor Prescription Drug Advertising Challenges - Life Sciences, Biotechnology & Nanotechnology
While pharmaceutical companies are most familiar with roles of the Food and Drug Administration (FDA)'s Office of Prescription Drug Promotion (OPDP) and Federal Trade Commission, prescription drug-focused companies may now also want to anticipate increased scrutiny of advertising by competitors.
Source: mondaq.com